VAV1 and neoplasm: In order to better understand the role of immune subsets other than T cells when genetically modified to express a chimeric antigen receptor against a tumor antigen, we took the approach of developing a mouse model in which the expression of a CAR was under the control of an immune specific promoter (vav), whose expression is integral in immune cell maturation and development.